WallStreetZenWallStreetZen

NASDAQ: PASG
Passage Bio Inc Stock Ownership - Who owns Passage Bio?

Insider buying vs selling

Have Passage Bio Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Kathleen BorthwickSVP INTERIM CFO2024-02-131,470$0.97
$1.43kSell
Mark S. FormanCHIEF MEDICAL OFFICER2024-02-131,638$0.97
$1.59kSell
Mark S. FormanChief Medical Officer2024-01-0215,813$0.91
$14.39kSell
Kathleen BorthwickSVP Interim CFO2024-01-0210,672$0.91
$9.71kSell
Edgar B. CaleGC Corporate Secretary2024-01-0215,813$0.91
$14.39kSell
Simona KingChief Financial Officer2023-07-2811,453$0.88
$10.08kSell
Orbimed Advisors LLC10% Owner2023-06-28575,195$0.84
$483.16kBuy
Orbimed Advisors LLC10% Owner2023-06-27617,382$0.84
$518.60kBuy
Alexandros FotopoulosChief Technical Officer2023-06-164,052$0.93
$3.78kSell

1 of 1

PASG insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PASG insiders and whales buy or sell their stock.

PASG Shareholders

What type of owners hold Passage Bio Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC25.15%13,981,323$17.76MInsider
Orbimed Advisors LLC18.21%10,124,576$12.86MInstitution
Patrick J. Heron9.01%5,009,219$6.36MInsider
Frazier Life Sciences Ix LP9.01%5,009,219$6.36MInsider
Versant Venture Capital Vi LP8.92%4,959,769$6.30MInsider
Thomas Woiwode8.92%4,959,769$6.30MInsider
Versant Venture Management LLC8.92%4,959,769$6.30MInstitution
Liam Ratcliffe4.71%2,619,430$3.33MInsider
New Leaf Venture Partners LLC4.49%2,497,922$3.17MInstitution
Tang Capital Management LLC4.32%2,400,000$3.05MInstitution

1 of 3

PASG vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PASG43.60%56.40%Net BuyingNet Selling
TIL4.92%95.08%
LABP4.53%95.47%
TLSA0.78%0.00%
CDTX25.63%15.98%Net SellingNet Selling

Passage Bio Stock Ownership FAQ

Who owns Passage Bio?

Passage Bio (NASDAQ: PASG) is owned by 53.47% institutional shareholders, 69.17% Passage Bio insiders, and 0.00% retail investors. Orbimed Advisors LLC is the largest individual Passage Bio shareholder, owning 13.98M shares representing 25.15% of the company. Orbimed Advisors LLC's Passage Bio shares are currently valued at $16.78M.

If you're new to stock investing, here's how to buy Passage Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.